Publication for Mki67 and Top2a

Species	Symbol	Function*	Entrez Gene ID*	Other ID	Gene coexpression	CoexViewer
mmu	Mki67	antigen identified by monoclonal antibody Ki 67	17345			[link]
mmu	Top2a	topoisomerase (DNA) II alpha	21973

Pubmed ID	Priority	Text
21846477	0.98	Top2a and mKi67, a proliferative marker, moderately in WT mice (~80%), but markedly (907% and 589%, respectively) in Nrf2-null mice (Fig. 4C).
	0.98	mKi67 and Top2a, as well as induction of proinflammatory genes Tnfalpha and Icam1, which is consistent with the tumor-promoting characteristic of TCDD.
18942075	0.98	Mki67, Odc, Plk1, Tk1, Top2a, Ung, and Tpx2 (Fig. 5A,B), and suggest that v-rasHa cannot abrogate the TGFbeta1 cell cycle arrest program.
22860109	0.98	Mki67, Smc2, Top2a, and Ube2c are all up-regulated in 7EX.
27884045	0.98	Top2a and Mki67 relative to controls (Fig. 3 G, H).
30500539	0.98	Mki67, Ccna2, Cdk1, Top2a and Cenpm (Figure 4D, S4A).
30604742	0.98	Top2a, Mki67, and Cdk1), multiple histone cluster 1 genes and Hells, a gene encoding a lymphoid-specific helicase involved in "lymphocyte proliferation".
24621249	0.97	Top2a (DNA topoisomerase 2-alpha), Mki67 and Birc5 (Survivin) are all highly expressed in CT26 cells.
	0.91	Top2a, Birc5 (Survivin), Cldn6 and Mki67, are highly expressed while differentiation and top-crypt markers Muc2, Ms4a8a (MS4A8B) and Epcam are not.
26485519	0.97	TOP2A and MKI67 was common to mouse exhausted CD8+ T cells and human CD39+ CD8+ T cells.
27811056	0.97	Top2a, Mki67 and Cdk1.
27840107	0.97	Top2a, Ccnb2, Mki67, Ccnb1) we identified the proportion of CMs with proliferative capacity during development (Fig S2B).
31444334	0.97	Top2a, Cdk1, Mki67, and Cenpa (Supplementary Fig. 2D), suggesting that subpopulation of tumor cells conferred tolerance to treatment or adapted to drug selection.
30038716	0.96	ki-67 and p-TOP2A, p-AURKB, p-CDC2, p-CDC20 and induce p21 in breast tumors derived from mice.
30635555	0.96	Mki67 and Top2a (Supplementary Figures 4 and 8, Supplementary Data 2).
29500128	0.95	Mki67, and Top2A of 1.3, 2.8 and 2.5 fold respectively, and a reduction of 3.8 fold for Ccnb1 (p = 0.07) compared to control treated PiZ mice (Fig. 3b).
24742461	0.94	mki67, as well as Ube2c, Ccna2, Prr11, and Top2a.
31522976	0.94	Ki67, Ccna2, Birc5, and Top2a, which are also expressed in cluster 4.
30402542	0.92	MKI67, TOP2A, TK1, and PCNA (Fig. 1C).
20886204	0.90	Mki67, cyclin A2 [Ccna2] and topoisomerase 2-alpha [Top2a]), mRNA expression profiles of which were tightly correlated (R > 0.95; p < 0.0001), both at the level of expression in tissues that widely differ in number of proliferating cells (ESM Fig. 4a), and at the level of islets at different time points of pregnancy (ESM Fig. 4b).
30778252	0.86	Mki67 and Top2a), while cluster 2 was distinguished by transcripts encoding molecules associated with effector CD8+ T cells (Cx3cr1, Klrc1 and Klrd1) (Supplementary Fig. 1b,c and Supplementary Table 1).
25590811	0.80	Ki67, Top2A) (Figure 4a).
24130333	0.73	Top2A, and Ki67 (Supplementary Fig. 1) provided results consistent with this conclusion.
29590628	0.60	Top2a and Mki67.